-transparent.png){kind=logo}
We have characterized plasma pharmacokinetics in 30 patients receiving mitomycin C (mitomycin) in doses ranging from 6 to 20 mg/m2 by iv bolus injection, either alone or in combination with other chemotherapeutic drugs. Plasma elimination of the drug was described by a two-compartment model in all but three cases, giving mean values for alpha-half-life of 8.2 mins, beta-half-life of 51.8 mins, and total body clearance of 332.9 ml/min/m2. The mean urinary excretion was 8.1% of the total dose administered. We did not detect alterations in pharmacologic parameters related to liver dysfunction, dose of mitomycin, and concomitant administration of other cytotoxic drugs.
Related Publications
G A van Hazel, and
M Scott, and
J Rubin, and
C G Moertel, and
R T Eagan, and
M J O'Connell, and
J S Kovach
January 1988,
Cancer chemotherapy and pharmacology,
G A van Hazel, and
M Scott, and
J Rubin, and
C G Moertel, and
R T Eagan, and
M J O'Connell, and
J S Kovach
September 1961,
The Journal of antibiotics,
G A van Hazel, and
M Scott, and
J Rubin, and
C G Moertel, and
R T Eagan, and
M J O'Connell, and
J S Kovach
March 1987,
Canadian journal of physiology and pharmacology,
G A van Hazel, and
M Scott, and
J Rubin, and
C G Moertel, and
R T Eagan, and
M J O'Connell, and
J S Kovach
January 1994,
Bulletin of the World Health Organization,
G A van Hazel, and
M Scott, and
J Rubin, and
C G Moertel, and
R T Eagan, and
M J O'Connell, and
J S Kovach
July 2016,
Journal of the National Cancer Institute,
G A van Hazel, and
M Scott, and
J Rubin, and
C G Moertel, and
R T Eagan, and
M J O'Connell, and
J S Kovach
April 1985,
Antimicrobial agents and chemotherapy,
G A van Hazel, and
M Scott, and
J Rubin, and
C G Moertel, and
R T Eagan, and
M J O'Connell, and
J S Kovach
January 1984,
Cancer treatment reports,
G A van Hazel, and
M Scott, and
J Rubin, and
C G Moertel, and
R T Eagan, and
M J O'Connell, and
J S Kovach
October 2000,
Pharmacology & toxicology,
G A van Hazel, and
M Scott, and
J Rubin, and
C G Moertel, and
R T Eagan, and
M J O'Connell, and
J S Kovach
July 2003,
Surgical oncology clinics of North America,
G A van Hazel, and
M Scott, and
J Rubin, and
C G Moertel, and
R T Eagan, and
M J O'Connell, and
J S Kovach
October 1983,
Cancer research,
